Pharmaceutical Products – Openhouse Procedure Various Active Pharmaceutical Ingredients From October 1St, 2024. Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Openhouse Procedure For Various Active Pharmaceutical Ingredients With The Earliest Possible Contract Start On October 1St, 2024. All Suitable And Interested Companies Are Offered The Opportunity To Conclude Or Join This Open House Contract, Subject To Uniform Contract Conditions And A Uniform Access Procedure. Interested Companies Can Download The Participation Documents In The Project Room Of The Dtvp Procurement Portal. The Prerequisite For Concluding An Open House Contract Is That The Interested Company Has Completely Completed And Signed The Requested Participation Documents And Submitted An Extract From The Commercial Register (Not Older Than Two Years). A Contract Will Be Concluded With Each Company That Meets The Participation Requirements. There Is No Exclusivity. Joining Or Concluding A Contract Can Take Place At Any Time And Under The Same Conditions. Individual Contract Negotiations Will Not Be Carried Out. The Earliest Start Of The Contract Is October 1St, 2024. If Aok Rheinland/Hamburg Carries Out A Tender For Exclusive Contracts In The Form Of An Open Procurement Procedure During The Contract Term, The Contracts Concluded Within The Scope Of This Publication Will Be Terminated In Accordance With The Contractual Regulations. The Specific Active Pharmaceutical Ingredients And The Respective Contract Starts Can Be Found In The Current List Of Active Pharmaceutical Ingredients In The Project Room Of The Dtvp Procurement Portal In The Procurement Documents Section. As Of October 1St, 2024, Contracts Are Being Offered For The Following Active Ingredients: Abacavir / Lamivudine / Zidovudine Acetylcysteine Non-Rx Acetylcysteine Rx Acetylsalicylic Acid Only Products That Can Be Prescribed According To Appendix 1 Am-Rl G-Ba Acitretin Aclidinium Bromide / Formoterol Adalimumab Adefovir Dipivoxil Alitretinoin Alprazolam Amantadine Amifampridine Aripiprazole Took Dar Tablets / Oral Tablets And Oral Solutions Atorvastatin / Ezetimibe Excluding Dosage Form Tab/Fta Beclometasone / Formoterol Beclometasone / Formoterol / Glycopyrronium Bimatoprost Biperiden Bortezomib Brinzolamide / Timolol Bromazepam Budesonide Excluding Inhalatives Buserelin Calcipotriol Calcium / Colecalciferol Captopril / Hydrochlorothiazide Ceftriaxone Chlorine Talidon Cinacalcet Excluding Dosage Form Film-Coated Clomipramine Only 75 Mg Retarded Clonidine Clostridium Botulinum Excluding Lifestyle Medications Colecalciferol Non-Rx Colistin Cyproterone Cyproterone / Ethinyl Estradiol Dabigatran Desloratadine Desogestrel / Ethinyl Estradiol Dexamethasone / Gentamicin Dienogest / Estradiol Diltiazem Dimethyl Fumarate Distigmine Doravirine / Lamivudine / Tenofovir Disoproxil Alpha Doxycycline Dronedarone Drospirenone / Ethinylestradiol Dutasteride / Tamsulosin Ebastine Iron Ii Oral Dar/Product That Can Only Be Prescribed According To Annex 1 Am-Rl G-Ba
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 80285402
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.
